Literature DB >> 12181285

Organic cation transporter mRNA and function in the rat superior cervical ganglion.

Doris Kristufek1, Walter Rudorfer, Christian Pifl, Sigismund Huck.   

Abstract

Reuptake of extracellular noradrenaline (NA) into superior cervical ganglion (SCG) neurones is mediated by means of the noradrenaline transporter (NAT, uptake 1). We now demonstrate by single-cell RT-PCR that mRNA of the organic cation transporter 3 (OCT3, uptake 2) occurs in rat SCG neurones as well. Furthermore, our RT-PCR analyses reveal the presence of mRNA for novel organic cation transporters 1 and 2 (OCTN1 and OCTN2), but not for OCT1 or OCT2 in the ganglion. Making use of the NAT as a powerful, neurone-specific transporter system, we loaded[3H]-N-methyl-4-phenylpyridinium ([3H]-MPP+) into cultured rat SCG neurones. The ensuing radioactive outflow from these cultures was enhanced by desipramine and reserpine, but reduced (in the presence of desipramine) by the OCT3 inhibitors cyanine 863, oestradiol and corticosterone. In contrast, cyanine 863 enhanced the radioactive outflow from cultures preloaded with [3H]-NA. Two observations suggest that a depletion of storage vesicles by cyanine 863 accounts for the latter phenomenon: first, the primary radioactive product isolated from supernatants of cultures loaded with [3H]-NA was the metabolite [3H]-DHPG; and second, inhibition of MAO significantly reduced the radioactive outflow in response to cyanine 863. The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters. However, desipramine at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of MPP+, indicating the NAT and not an OCT as their primary site of action. The MPP+-induced release of [3H]-MPP+ was fully prevented by a combined application of desipramine and cyanine 863. No trans-stimulation of [3H]-MPP+ outflow was observed by the OCTN1 and OCTN2 substrate carnitine at 100 microM. Our observations indicate an OCT-mediated transmembrane transport of [3H]-MPP+. Amongst the three OCTs expressed in the SCG, OCT3 best fits the profile of substrates and antagonists that cause trans-stimulation and trans-inhibition, respectively, of [3H]-MPP+ release.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181285      PMCID: PMC2290488          DOI: 10.1113/jphysiol.2002.021170

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  55 in total

Review 1.  Catecholamine reuptake and storage. Overview.

Authors:  H Bönisch; L Eiden
Journal:  Adv Pharmacol       Date:  1998

2.  Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has potent effects on the inactivation of circulating noradrenaline and adrenaline in conscious rat.

Authors:  G Eisenhofer; R McCarty; K Pacak; H Russ; E Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

Review 3.  Vesicular neurotransmitter transporters: from bacteria to humans.

Authors:  S Schuldiner; A Shirvan; M Linial
Journal:  Physiol Rev       Date:  1995-04       Impact factor: 37.312

4.  Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1.

Authors:  P Arndt; C Volk; V Gorboulev; T Budiman; C Popp; I Ulzheimer-Teuber; A Akhoundova; S Koppatz; E Bamberg; G Nagel; H Koepsell
Journal:  Am J Physiol Renal Physiol       Date:  2001-09

5.  The force driving the extraneuronal transport mechanism for catecholamines (uptake2).

Authors:  E Schömig; J Babin-Ebell; H Russ; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

6.  Cloning and characterization of two human polyspecific organic cation transporters.

Authors:  V Gorboulev; J C Ulzheimer; A Akhoundova; I Ulzheimer-Teuber; U Karbach; S Quester; C Baumann; F Lang; A E Busch; H Koepsell
Journal:  DNA Cell Biol       Date:  1997-07       Impact factor: 3.311

7.  Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.

Authors:  I Tamai; R Ohashi; J Nezu; H Yabuuchi; A Oku; M Shimane; Y Sai; A Tsuji
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

8.  Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.

Authors:  A E Busch; U Karbach; D Miska; V Gorboulev; A Akhoundova; C Volk; P Arndt; J C Ulzheimer; M S Sonders; C Baumann; S Waldegger; F Lang; H Koepsell
Journal:  Mol Pharmacol       Date:  1998-08       Impact factor: 4.436

9.  Transport of monoamine transmitters by the organic cation transporter type 2, OCT2.

Authors:  D Gründemann; S Köster; N Kiefer; T Breidert; M Engelhardt; F Spitzenberger; N Obermüller; E Schömig
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

10.  alpha 2-Adrenoreceptor-mediated inhibition of acetylcholine-induced noradrenaline release from rat sympathetic neurons: an action at voltage-gated Ca2+ channels.

Authors:  S Boehm; S Huck
Journal:  Neuroscience       Date:  1995-11       Impact factor: 3.590

View more
  11 in total

1.  Selective deletion of the alpha5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse.

Authors:  Harald Fischer; Avi Orr-Urtreger; Lorna W Role; Sigismund Huck
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

Review 2.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

3.  Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission.

Authors:  Paul J Gasser; Christopher A Lowry; Miles Orchinik
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

4.  Decreased anxiety in mice lacking the organic cation transporter 3.

Authors:  Thomas Wultsch; Gundula Grimberg; Angelika Schmitt; Evelin Painsipp; Heike Wetzstein; Alexandra Frauke Stephanie Breitenkamp; Dirk Gründemann; Edgar Schömig; Klaus-Peter Lesch; Manfred Gerlach; Andreas Reif
Journal:  J Neural Transm (Vienna)       Date:  2009-03-11       Impact factor: 3.575

Review 5.  The SLC22 drug transporter family.

Authors:  Hermann Koepsell; Hitoshi Endou
Journal:  Pflugers Arch       Date:  2003-07-19       Impact factor: 3.657

Review 6.  Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy.

Authors:  Lynette C Daws
Journal:  Pharmacol Ther       Date:  2008-10-29       Impact factor: 12.310

Review 7.  Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.

Authors:  Hermann Koepsell; Katrin Lips; Christopher Volk
Journal:  Pharm Res       Date:  2007-05-01       Impact factor: 4.580

8.  Decreased biosynthesis of lung surfactant constituent phosphatidylcholine due to inhibition of choline transporter by gefitinib in lung alveolar cells.

Authors:  Naoki Ishiguro; Masanobu Oyabu; Toshihiro Sato; Tomoji Maeda; Hironobu Minami; Ikumi Tamai
Journal:  Pharm Res       Date:  2007-07-12       Impact factor: 4.580

Review 9.  Membrane transporters as mediators of Cisplatin effects and side effects.

Authors:  Giuliano Ciarimboli
Journal:  Scientifica (Cairo)       Date:  2012-11-25

10.  An unsuspected role for organic cation transporter 3 in the actions of amphetamine.

Authors:  Felix P Mayer; Diethart Schmid; W Anthony Owens; Georgianna G Gould; Mia Apuschkin; Oliver Kudlacek; Isabella Salzer; Stefan Boehm; Peter Chiba; Piper H Williams; Hsiao-Huei Wu; Ulrik Gether; Wouter Koek; Lynette C Daws; Harald H Sitte
Journal:  Neuropsychopharmacology       Date:  2018-04-06       Impact factor: 8.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.